The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells

Molecular Endocrinology

Volumn 18, Issue 9, 2004, Pages 2268-2278

  Grey, Andrew ^a   Banovic, Tatjana ^a   Zhu, Qing ^a   Watson, Maureen ^a   Callon, Karen ^a   Palmano, Kate ^b   Ross, Jacqueline ^a   Naot, Dorit ^a   Reid, Ian R ^a   Cornish, Jillian ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b FONTERRA RESEARCH CENTRE   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOFERRIN; LECTIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN ASSOCIATED PROTEIN; MEGALIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P44;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCYTOSIS; FIBROBLAST; HUMAN; HUMAN CELL; LIPOPROTEIN DEFICIENCY; MITOGENESIS; NEWBORN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; ENDOCYTOSIS; ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION; LACTOFERRIN; LDL-RECEPTOR RELATED PROTEIN 1; LDL-RECEPTOR RELATED PROTEIN 2; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGENS; OSTEOBLASTS; PROTEIN TRANSPORT; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 4544317903     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2003-0456     Document Type: Article

References (50)

1. Cummings SR, Melton LJ 2002 Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761-1767
2. Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C, The Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group 2002 Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570-578
3. Rosen CJ, Bilezikian JP 2001 Clinical review 123: anabolic therapy for osteoporosis. J Clin Endocrinol Metab 86:957-964
4. Cornish J, Callon KE, Naot D, Palmano KP, Banovic T, Bava U, Watson M, Lin J-M, Tong PC, Chen Q, Chan VA, Reid HE, Fazzalari N, Baker HM, Baker EN, Haggarty NW, Grey AB, Reid IR 2004 Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145:4366-4374
5. Lonnerdal B, Iyer S 1995 Lactoferrin: molecular structure and biological function. Annu Rev Nutr 15:93-110
6. Ward PP, Uribe-Luna S, Conneely OM 2002 Lactoferrin and host defence. Biochem Cell Biol 80:95-102
7. Metz-Boutigue MH, Jolles J, Mazurier J, Schoentgen F, Legrand D, Spik G, Montreuil J, Jolies P 1984 Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur J Biochem 145:659-676
8. Bi BY, Lefebvre AM, Dus D, Spik G, Mazurier J 1997 Effect of lactoferrin on proliferation and differentiation of the Jurkat human lymphoblastic T cell line. Arch Immunol Ther Exp (Warsz) 45:315-320
9. Ward PP, Mendoza-Meneses M, Mulac-Jericevic B, Cunningham GA, Saucedo-Cardenas O, Teng CT, Conneely OM 1999 Restricted spatiotemporal expression of lactoferrin during murine embryonic development. Endocrinology 140:1852-1860
10. Sawatzki G, Rich IN 1989 Lactoferrin stimulates colony stimulating factor production in vitro and in vivo. Blood Cells 15:371-385
11. Baveye S, Elass E, Fernig DG, Blanquart C, Mazurier J, Legrand D 2000 Human lactoferrin interacts with soluble CD14 and inhibits expression of endothelial adhesion molecules, E-selectin and ICAM-1, induced by the CD14-lipopolysaccharide complex. Infect Immun 68:6519-6525
12. Guillen C, Mclnnes IB, Vaughan DM, Kommajosyula S, Van Berkel PH, Leung BP, Aguila A, Brock JH 2002 Enhanced Th1 response to Staphylococcus aureus infection in human lactoferrin-transgenic mice. J Immunol 168:3950-3957
13. Kimber I, Cumberbatch M, Dearman RJ, Headon DR, Bhushan M, Griffiths CE 2002 Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem Cell Biol 80:103-107
14. Elass E, Masson M, Mazurier J, Legrand D 2002 Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect Immun 70:1860-1866
15. Frydecka I, Zimecki M, Bocko D, Kosmaczewska A, Teodorowska R, Ciszak L, Kruzel M, Wlodarska-Polinsk J, Kuliczkowski K, Kornafel J 2002 Lactoferrin-induced up-regulation of ζ chain expression in peripheral blood T lymphocytes from cervical cancer patients. Anticancer Res 22:1897-1901
16. Baveye S, Elass E, Mazurier J, Spik G, Legrand D 1999 Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin Chem Lab Med 37:281-286
17. Willnow TE, Goldstein JL, Orth K, Brown MS, Herz J 1992 Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J Biol Chem 267:26172-26180
18. Meilinger M, Haumer M, Szakmary KA, Steinbock F, Scheiber B, Goldenberg H, Huettinger M 1995 Removal of lactoferrin from plasma is mediated by binding to low density lipoprotein receptor-related protein/α 2-macroglobulin receptor and transport to endosomes. FEBS Lett 360:70-74
19. Ji ZS, Mahley RW 1994 Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler Thromb 14:2025-2031
20. Vash B, Phung N, Zein S, DeCamp D 1998 Three complement-type repeats of the low-density lipoprotein receptor-related protein define a common binding site for RAP, PAI-1, and lactoferrin. Blood 92:3277-3285
21. Strickland DK, Gonias SL, Argraves WS 2002 Diverse roles for the LDL receptor family. Trends Endocrinol Metab 13:66-74
22. Herz J, Gotthardt M, Willnow TE 2000 Cellular signalling by lipoprotein receptors. Curr Opin Lipidol 11:161-166
23. Li Y, Cam J, Bu G 2001 Low-density lipoprotein receptor family: endocytosis and signal transduction. Mol Neurobiol 23:53-67
24. Legrand D, Vigie K, Said EA, Elass E, Masson M, Slomianny MC, Carpentier M, Briand JP, Mazurier J, Hovanessian AG 2004 Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 271:303-317
25. Talukder MJ, Takeuchi T, Harada E 2003 Receptor-mediated transport of lactoferrin into the cerebrospinal fluid via plasma in young calves. J Vet Med Sci 65:957-964
26. Talukder MJ, Takeuchi T, Harada E 2003 Characteristics of lactoferrin receptor in bovine intestine: higher binding activity to the epithelium overlying Peyer's patches. J Vet Med A Physiol Pathol Clin Med 50:123-131
27. Gliemann J 1998 Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. Biol Chem 379:951-964
28. Barmina OY, Walling HW, Fiacco GJ, Freije JM, Lopez-Otin C, Jeffrey JJ, Partridge NC 1999 Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. J Biol Chem 274:30087-30093
29. Orr AW, Pedraza CE, Pallero MA, Elzie CA, Goicoechea S, Strickland DK, Murphy-Ullrich JE 2003 Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly. J Cell Biol [Erratum (2003) 162:521] 161:1179-1189
30. Robinson MJ, Cobb MH 1997 Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9:180-186
31. Kanyshkova TG, Semenov DV, Buneva VN, Nevinsky GA 1999 Human milk lactoferrin binds two DNA molecules with different affinities. FEBS Lett 451:235-237
32. He J, Furmanski P 1995 Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 373:721-724
33. Fleet JC 1995 A new role for lactoferrin: DNA binding and transcription activation. Nutr Rev 53:226-227
34. Loukinova E, Ranganathan S, Kuznetsov S, Gorlatova N, Migliorini MM, Loukinov D, Ulery PG, Mikhailenko I, Lawrence DA, Strickland DK 2002 Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function between LRP and the PDGF. J Biol Chem 277:15499-15506
35. Boucher P, Liu P, Gotthardt M, Hiesberger T, Anderson RG, Herz J 2002 Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae. J Biol Chem 277:15507-15513
36. Dhennin-Duthille I, Masson M, Damiens E, Fillebeen C, Spik G, Mazurier J 2000 Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line. J Cell Biochem 79:583-593
37. Takayama Y, Takahashi H, Mizumachi K, Takezawa T 2003 Low density lipoprotein receptor-related protein (LRP) is required for lactoferrin-enhanced collagen gel contractile activity of human fibroblasts. J Biol Chem 278:22112-22118
38. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, ArslanKirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, et al. 2001 LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107:513-523
39. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass II DA, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L 2002 Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol 157:303-314
40. Kharode Y, Green P, Marzolf J, Zhao W, Askew R, Yaworsky P, Bex F 2003 Alteration in bone density of mice due to heterozygous inactivation of LRP6. J Bone Miner Res 18(Suppl 2):60 (Abstract)
41. Shah BH, Alberto Olivares-Reyes J, Yesilkaya A, Catt KJ 2002 Independence of angiotensin II-induced MAP kinase activation from angiotensin type 1 receptor internalization in clone 9 hepatocytes. Mol Endocrinol 16:610-620
42. Chen Z, Rola-Pleszczynski M, Stankova J 2003 Activation of ERK1/2 by platelet-activating factor is independent of receptor internalization and G-protein activation. Cell Signal 15:843-850
43. Hussain MM 2001 Structural, biochemical and signaling properties of the low-density lipoprotein receptor gene family. Front Biosci 6:D417-D428
44. Grey A, Banovic T, Naot D, Hill B, Callon K, Reid I, Cornish J 2001 Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not p42/44 mitogen-activated protein kinases. Endocrinology 142:1098-1106
45. Palmano KP, Elgar DF 2002 Detection and quantitation of lactoferrin in bovine whey samples by reversed-phase high-performance liquid chromatography on polystyrene-divinylbenzene. J Chromatogr A 947:307-311
46. Brock JH, Arzabe FR 1976 Cleavage of diferric bovine transferrin into two monoferric fragments. FEBS Lett 69:63-66
47. Bates GW, Billups C, Saltman P 1967 The kinetics and mechanism of iron exchange between chelates and transferrin. I. The complexes of citrate and nitrilotriacetic acid. J Biol Chem 242:2810-2815
48. Parry RM, Brown EM 1974 Protein-metal interactions. In: Friedman M, ed. Advances in experimental medicine and biology. New York: Plenum;141-160
49. Stowell KM, Rado TA, Funk WD, Tweedie JW 1991 Expression of cloned human lactoferrin in baby-hamster kidney cells. Biochem J 276:349-355
50. Naot D, Callon KE, Grey A, Cooper GJS, Reid IR, Cornish J 2001 A potential role for adrenomedullin as a local regulator of bone growth. Endocrinology 142:1849-1857